← Portal hypertension & cirrhosis
Papers in Portal hypertension & cirrhosis
Page 2 · newest first
- Pharmacotherapy for Cirrhosis in JapanPortal hypertension & cirrhosis · 2025
- The Prognostic Significance of Handgrip Strength in Cirrhosis: Simplicity Is the Ultimate SophisticationPortal hypertension & cirrhosis · 2025
- Portal Hypertension—Noninvasive Multiparametric Ultrasound‐Based Criteria and MeasurementsPortal hypertension & cirrhosis · 2025
- A Combined Model of Spleen Stiffness and Baveno VII Criteria for Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease: An International Multicenter StudyPortal hypertension & cirrhosis · 2025
- LiverRCT IIT : Promoting Investigator‐Initiated Randomized Controlled Trials for the Key Clinical Issues in Liver Disease Prevention and TreatmentPortal hypertension & cirrhosis · 2025
- Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated CirrhosisPortal hypertension & cirrhosis · 2025
- The Chinese Herbal TiaoGanXiaoZhi Formula Alleviates the Progression of Metabolic‐Associated Fatty Liver Disease by Regulating the Gut MicrobiotaPortal hypertension & cirrhosis · 2025
- Research Progress of Noninvasive Evaluation of Portal Hypertension by Blood‐Based TestsPortal hypertension & cirrhosis · 2025
- Resmetirom and Thyroid Hormone Receptor‐Targeted Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD)Portal hypertension & cirrhosis · 2025
- Application of graph theory in liver research: A reviewPortal hypertension & cirrhosis · 2024
- Dawn of an era of effective treatments for MAFLDPortal hypertension & cirrhosis · 2024
- Molecular mechanisms of hepatic lipid metabolism disorders: Focus on mitochondrial quality controlPortal hypertension & cirrhosis · 2024
- Portal hypertension as an independent risk factor for cirrhotic cardiomyopathy: An investigation on its mechanism based on bioinformatics analysisPortal hypertension & cirrhosis · 2024
- Psoas muscle index in sarcopenia following transjugular intrahepatic portosystemic shunt: A multicenter, retrospective studyPortal hypertension & cirrhosis · 2024
- Exploring the predictive value of serum lipids for short‐term prognosis in patients with acute‐on‐chronic liver failurePortal hypertension & cirrhosis · 2024
- Nationwide survey analysis of esophagogastric varices in portal hypertension based on endoscopic management in ChinaPortal hypertension & cirrhosis · 2024
- Appraising the causal effects of circulating micronutrients on liver cirrhosis: Evidence from large‐scale Mendelian randomization analysisPortal hypertension & cirrhosis · 2024
- Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023Portal hypertension & cirrhosis · 2024
- Role of post‐hepatectomy portal hypertension in predicting the outcome of hepatocellular carcinoma after curative resectionPortal hypertension & cirrhosis · 2024
- Application of subharmonic‐aided pressure estimation in a patient with giant hepatic cyst: A case reportPortal hypertension & cirrhosis · 2024
- Tumor budding is a meaningful prognostic marker in patients with hepatocellular carcinoma after curative hepatectomyPortal hypertension & cirrhosis · 2024
- Endoscopic ultrasound‐guided portal pressure gradient identifies patients with previously undiagnosed clinically significant portal hypertensionPortal hypertension & cirrhosis · 2024
- Sequential or simultaneous transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: A retrospective real‐world studyPortal hypertension & cirrhosis · 2024
- Progress in the diagnosis and treatment of graft fibrosis after liver transplantationPortal hypertension & cirrhosis · 2024
- Global status and trends in hepatitis B virus DNA mutation research from 2003 to 2022: A comprehensive bibliometric viewPortal hypertension & cirrhosis · 2024
- Dual neovascular targets of vascular endothelial growth factor receptors and platelet‐derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in ratsPortal hypertension & cirrhosis · 2024
- Serum markers for detecting histological features of autoimmune hepatitis and predicting prognosis in patients with antinuclear antibody‐positive drug‐induced liver injuryPortal hypertension & cirrhosis · 2024
- One‐year status of hepatic venous pressure gradient measurement from 85 hospitals in ChinaPortal hypertension & cirrhosis · 2024
- Innovations in endoscopic ultrasound for portal hypertension and its role in managing complications in clinical practice: Lessons learned from a tertiary referral public hospitalPortal hypertension & cirrhosis · 2024
- Treatment strategy for erythropoietic protoporphyria accompanied by severe abdominal pain and liver injuryPortal hypertension & cirrhosis · 2024
- Global burden trends of MAFLD‐related liver cancer from 1990 to 2019Portal hypertension & cirrhosis · 2023
- Comparison of patients with hepatitis B virus‐associated hepatocellular carcinoma: Data from two hospitals from Turkey and ChinaPortal hypertension & cirrhosis · 2023
- Sleep disturbances in patients with cirrhosis: Pursuing just rightPortal hypertension & cirrhosis · 2023
- Prevalence and risk factors for minimal hepatic encephalopathy in cirrhotic patients with different etiologiesPortal hypertension & cirrhosis · 2023
- Ten important original articles in the field of cirrhosis and portal hypertension from ChinaPortal hypertension & cirrhosis · 2023
- Comparison of prevention and treatment of portal vein thrombosis between proximal splenic vein ligation followed by postoperative transcatheter anticoagulant therapy and systemic anticoagulant therapy in patients with cirrhotic portal hypertensionPortal hypertension & cirrhosis · 2023
- Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascitesPortal hypertension & cirrhosis · 2023
- MicroRNAs as critical regulators in liver fibrosisPortal hypertension & cirrhosis · 2023
- Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter studyPortal hypertension & cirrhosis · 2023
- Investigation on the short‐term outcome and prognostic impact of predisposition, and precipitants in inpatients with chronic liver disease from Chinese AcuTe on CHronic LIver FailurE (CATCH‐LIFE) cohortsPortal hypertension & cirrhosis · 2023
- Portal vein thrombosis in liver cirrhosis: An updated overviewPortal hypertension & cirrhosis · 2023
- Quantitative computed tomography‐based approaches for noninvasive diagnosis of portal hypertension in patients with cirrhosisPortal hypertension & cirrhosis · 2023
- Hepatic venous pressure gradient measurement guiding nonselective beta‐blocker therapy in a patient with clinically significant portal hypertensionPortal hypertension & cirrhosis · 2023
- Stories behind the coverPortal hypertension & cirrhosis · 2023
- Subharmonic aided pressure estimation in portal hypertension: A noninvasive ultrasound‐based technique to assess portal pressure gradientPortal hypertension & cirrhosis · 2023
- A patient with dyskeratosis congenita and portal hypertensionPortal hypertension & cirrhosis · 2023
- Three‐dimensional magnetic resonance elastography in chronic liver diseasePortal hypertension & cirrhosis · 2023
- Global scientific trends on portal hypertension and cirrhosis in the 21st century: A bibliometric and visualized analysisPortal hypertension & cirrhosis · 2023
- Traditional Chinese medicine targets on hepatic stellate cells for the treatment of hepatic fibrosis: A mechanistic reviewPortal hypertension & cirrhosis · 2023
- Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China: A national survey analysisPortal hypertension & cirrhosis · 2023